financetom
Business
financetom
/
Business
/
Costco Stock Falls Nearly 4% After May Sales Report Despite Solid Growth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Costco Stock Falls Nearly 4% After May Sales Report Despite Solid Growth
Jun 5, 2025 12:31 PM

Costco Wholesale Corp. ( COST ) shares are trading lower Thursday after the company released its May sales report.

What To Know: For the four-week period ending June 1, 2025, Costco reported net sales of $20.97 billion, up 6.8% from $19.64 billion a year earlier. For the first 39 weeks of the fiscal year, total net sales reached $201.02 billion, an 8% increase compared to $186.07 billion last year.

Comparable sales rose 4.3% for May across the company. In the U.S., comparable sales were up just 4.1%, while international markets like Canada and other regions rose 3.3% and 6.6%, respectively. E-commerce continued to show stronger growth, up 11.6% for the month.

Stripping out the effects of gasoline prices and foreign exchange, comparable sales were stronger, 6% for the total company, including 5.5% in the U.S. and 12% in e-commerce. However, even those numbers didn't prevent the stock from falling sharply.

One reason for the selloff may be that U.S. same-store sales growth, while positive, lagged behind inflation and didn’t show a major acceleration. Gross margin and membership revenue details weren't included in the May report, leaving gaps in the picture of overall profitability and operational efficiency. Inventory and cost pressures, common issues in the retail sector, may also be on investors’ minds.

Costco's sharp drop in share price suggests the market may have been expecting more aggressive growth, especially given the stock's high valuation. Despite strong year-to-date performance, the nearly 4% decline indicates that investors are looking beyond top-line growth and focusing on margin trends, U.S. consumer demand and the broader retail environment.

COST Price Action: Costco shares were down 4.01% at $1009.47 at the time of writing, according to Benzinga pro.

Read Next:

Trump Announces China Trade Talks, Tesla Stock Slumps: What’s Driving Markets Thursday?

Image Via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Onex Fund to Acquire a Majority Stake in German Manufacturer Fischbach KG
Onex Fund to Acquire a Majority Stake in German Manufacturer Fischbach KG
Aug 24, 2024
04:51 PM EDT, 08/22/2024 (MT Newswires) -- Onex ( ONEXF ) on Thursday said its Onex Partners Opportunities Fund is taking a majority stake in German manufacturer Fischbach KG for an undisclosed price. The private equity company said Fischbach is the world's largest provider of cartridge packaging solutions for sealants and adhesives used in building repair, renovation, & construction, aftermarket...
Advanced Micro Devices Insider Sold Shares Worth $12,595,575, According to a Recent SEC Filing
Advanced Micro Devices Insider Sold Shares Worth $12,595,575, According to a Recent SEC Filing
Aug 24, 2024
04:17 PM EDT, 08/22/2024 (MT Newswires) -- Lisa T Su, Director, Chair, President & CEO, on August 20, 2024, sold 80,000 shares in Advanced Micro Devices ( AMD ) for $12,595,575. Following the Form 4 filing with the SEC, Su has control over a total of 4,184,892 shares of the company, with 3,566,762 shares held directly and 618,130 controlled indirectly....
Intuit Beats Fiscal Fourth-Quarter Views on Gains From QuickBooks, Credit Karma
Intuit Beats Fiscal Fourth-Quarter Views on Gains From QuickBooks, Credit Karma
Aug 24, 2024
04:58 PM EDT, 08/22/2024 (MT Newswires) -- Intuit (INTU) late Thursday reported stronger-than-expected fiscal fourth-quarter results, driven by revenue gains in the financial technology platform's QuickBooks and Credit Karma offerings. Adjusted per-share earnings jumped to $1.99 during the three months ended July 31 from $1.65 a year earlier, topping the consensus compiled by Capital IQ of $1.85. Revenue increased 17%...
Jazz Pharmaceuticals Epilepsies Drug Study Misses Primary Efficacy Goal
Jazz Pharmaceuticals Epilepsies Drug Study Misses Primary Efficacy Goal
Aug 24, 2024
04:48 PM EDT, 08/22/2024 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) said Thursday a phase 3 trial in Japan of a cannabidiol oral solution for treatment-resistant epilepsies didn't meet the primary efficacy objective. The trial did not meet the primary efficacy endpoint of a pre-specified percentage change in indication-associated seizure frequency during the treatment period (up to 16 weeks)...
Copyright 2023-2026 - www.financetom.com All Rights Reserved